These include infliximab, another TNF-α inhibitor [65]; ustekinumab, an IL-12/IL-23 inhibitor commonly used in psoriasis and CD [66]; and secukinumab [67], an IL-17 inhibitor. The gene discussed is IL17A; the disease is psoriasis.